Nurix Therapeutics, Inc. - COM (NRIX)

Historical Portfolio Holders from Q3 2020 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
65M
Holdings value Q2 2024
$1.36B
Value change Q2 2024
+$344M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
172
Number of buys Q2 2024
109
Number of sells Q2 2024
-61
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 65M $1.36B +$344M $20.87 172
2024 Q1 48.9M $718M +$58.4M $14.70 134
2023 Q4 46M $475M -$21.3M $10.32 125
2023 Q3 44.8M $352M +$8.51M $7.86 127
2023 Q2 43.6M $435M +$11.8M $9.99 122
2023 Q1 42.3M $375M -$3.62M $8.88 118
2022 Q4 42.7M $469M +$2.14M $10.98 118
2022 Q3 42.6M $555M -$36.7M $13.03 111
2022 Q2 43.5M $551M +$51.9M $12.67 96
2022 Q1 40.1M $561M -$19.1M $14.01 108
2021 Q4 40.4M $1.17B +$25.7M $28.95 117
2021 Q3 38.9M $1.17B -$6.52M $29.96 109
2021 Q2 39.1M $1.04B -$75.6M $26.53 101
2021 Q1 41.3M $1.29B +$255M $31.09 98
2020 Q4 33.1M $1.09B +$26.9M $32.88 67
2020 Q3 31.9M $1.11B +$1.11B $34.91 64